Poniard halves workforce and struggles on with picoplatin
04 February 2010
Sukaina Virji
Please Login to read the full article.
04 February 2010
Sukaina Virji
sukaina.virji@informa.com
Poniard Pharmaceuticals is to reduce its workforce by more than a half to 21 employees and is focusing all remaining resources to advance the ongoing clinical development of its anticancer picoplatin.
This follows a series of development setbacks with picoplatin, Poniard's only clinical programme.
Last...
Please Login to read the full article.
RELATED CONTENT
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
